Validity of the Adult ADHD Self-Report Scale (ASRS) As a Screener for Adult ADHD in Treatment Seeking Substance Use Disorder Patients

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2013 May 11

PMID 23660242

Citations 63

Authors

Geurt Van de Glind

Wim van den Brink

Maarten W J Koeter

Pieter-Jan Carpentier

Katelijne van Emmerik-van Oortmerssen

Sharlene Kaye

Arvid Skutle

Eli-Torild H Bu

Johan Franck

Maija Konstenius

Franz Moggi

Geert Dom

Sofie Verspreet

Zsolt Demetrovics

Mate Kapitany-Foveny

Melina Fatseas

Marc Auriacombe

Arild Schillinger

Andrea Seitz

Brian Johnson

Stephen V Faraone

J Antoni Ramos-Quiroga

Miguel Casas

Steve Allsop

Susan Carruthers

Csaba Barta

Robert A Schoevers

Frances R Levin

Affiliations

Soon will be listed here.

Abstract

Background: To detect attention deficit hyperactivity disorder (ADHD) in treatment seeking substance use disorders (SUD) patients, a valid screening instrument is needed.

Objectives: To test the performance of the Adult ADHD Self-Report Scale V 1.1(ASRS) for adult ADHD in an international sample of treatment seeking SUD patients for DSM-IV-TR; for the proposed DSM-5 criteria; in different subpopulations, at intake and 1-2 weeks after intake; using different scoring algorithms; and different externalizing disorders as external criterion (including adult ADHD, bipolar disorder, antisocial and borderline personality disorder).

Methods: In 1138 treatment seeking SUD subjects, ASRS performance was determined using diagnoses based on Conner's Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as gold standard.

Results: The prevalence of adult ADHD was 13.0% (95% CI: 11.0-15.0%). The overall positive predictive value (PPV) of the ASRS was 0.26 (95% CI: 0.22-0.30), the negative predictive value (NPV) was 0.97 (95% CI: 0.96-0.98). The sensitivity (0.84, 95% CI: 0.76-0.88) and specificity (0.66, 95% CI: 0.63-0.69) measured at admission were similar to the sensitivity (0.88, 95% CI: 0.83-0.93) and specificity (0.67, 95% CI: 0.64-0.70) measured 2 weeks after admission. Sensitivity was similar, but specificity was significantly better in patients with alcohol compared to (illicit) drugs as the primary substance of abuse (0.76 vs. 0.56). ASRS was not a good screener for externalizing disorders other than ADHD.

Conclusions: The ASRS is a sensitive screener for identifying possible ADHD cases with very few missed cases among those screening negative in this population.

Citing Articles

ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions.

Hernandez M, Levin F, Campbell A CNS Drugs. 2025; .

PMID: 39979544 DOI: 10.1007/s40263-025-01168-6.

The Role of Smartphone Use in Sensory Processing: Differences Between Adolescents with ADHD and Typical Development.

Fabio R, Suriano R Int J Environ Res Public Health. 2025; 21(12.

PMID: 39767544 PMC: 11728006. DOI: 10.3390/ijerph21121705.

Gene - maltreatment interplay in adult ADHD symptoms: main role of a gene-environment correlation effect in a Brazilian population longitudinal study.

Tovo-Rodrigues L, Camerini L, Martins-Silva T, Carpena M, Bonilla C, Oliveira I Mol Psychiatry. 2024; 29(11):3412-3421.

PMID: 38744991 DOI: 10.1038/s41380-024-02589-3.

Are We Measuring ADHD or Anxiety? Examining the Factor Structure and Discriminant Validity of the Adult ADHD Self-Report Scale in an Adult Anxiety Disorder Population.

Alarachi A, Merrifield C, Rowa K, McCabe R Assessment. 2024; 31(7):1508-1524.

PMID: 38288573 PMC: 11409565. DOI: 10.1177/10731911231225190.

Prevalence of Undiagnosed Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in the Young Adult Population of the United Arab Emirates: A National Cross-Sectional Study.

Al-Yateem N, Slewa-Younan S, Halimi A, Saeed S, Tliti D, Mohammad M J Epidemiol Glob Health. 2023; 14(1):45-53.

PMID: 38079098 PMC: 11043292. DOI: 10.1007/s44197-023-00167-4.

References

Grant B, Hasin D, Stinson F, Dawson D, Chou S, Ruan W . Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions. J Psychiatr Res. 2004; 39(1):1-9. DOI: 10.1016/j.jpsychires.2004.05.004. View

Cerda M, Sagdeo A, Galea S . Comorbid forms of psychopathology: key patterns and future research directions. Epidemiol Rev. 2008; 30:155-77. DOI: 10.1093/epirev/mxn003. View

Kessler R, Adler L, Ames M, Demler O, Faraone S, Hiripi E . The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005; 35(2):245-56. DOI: 10.1017/s0033291704002892. View

Barkley R, Fischer M, Smallish L, Fletcher K . The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002; 111(2):279-89. View

Wilens T, Fusillo S . When ADHD and substance use disorders intersect: relationship and treatment implications. Curr Psychiatry Rep. 2007; 9(5):408-14. DOI: 10.1007/s11920-007-0053-3. View

Williams J, GIBBON M, First M, Spitzer R, Davies M, Borus J . The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992; 49(8):630-6. DOI: 10.1001/archpsyc.1992.01820080038006. View

Rukstalis M, Jepson C, Patterson F, Lerman C . Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat. 2005; 28(4):297-304. DOI: 10.1016/j.jsat.2005.02.002. View

Epstein J, Kollins S . Psychometric properties of an adult ADHD diagnostic interview. J Atten Disord. 2006; 9(3):504-14. DOI: 10.1177/1087054705283575. View

Simon V, Czobor P, Balint S, Meszaros A, Bitter I . Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009; 194(3):204-11. DOI: 10.1192/bjp.bp.107.048827. View

10.

Medori R, Ramos-Quiroga J, Casas M, Kooij J, Niemela A, Trott G . A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008; 63(10):981-9. DOI: 10.1016/j.biopsych.2007.11.008. View

11.

King V, Brooner R, Kidorf M, Stoller K, MIRSKY A . Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis. 1999; 187(8):487-95. DOI: 10.1097/00005053-199908000-00005. View

12.

Shrout P, Newman S . Design of two-phase prevalence surveys of rare disorders. Biometrics. 1989; 45(2):549-55. View

13.

Van de Glind G, van Emmerik-van Oortmerssen K, Carpentier P, Levin F, Koeter M, Barta C . The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res. 2013; 22(3):232-44. PMC: 4085151. DOI: 10.1002/mpr.1397. View

14.

Wise B, Cuffe S, Fischer T . Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat. 2001; 21(3):161-5. DOI: 10.1016/s0740-5472(01)00193-3. View

15.

Daigre Blanco C, Ramos-Quiroga J, Valero S, Bosch R, Roncero C, Gonzalvo B . Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders. Actas Esp Psiquiatr. 2010; 37(6):299-305. View

16.

Wittchen H, ROBINS L, Cottler L, Sartorius N, Burke J, Regier D . Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry. 1991; 159:645-53, 658. DOI: 10.1192/bjp.159.5.645. View

17.

Ercan E, Coskunol H, Varan A, Toksoz K . Childhood attention deficit/hyperactivity disorder and alcohol dependence: a 1-year follow-up. Alcohol Alcohol. 2003; 38(4):352-6. DOI: 10.1093/alcalc/agg084. View

18.

Wilens T . Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry. 2004; 65 Suppl 3:38-45. View

19.

Adler L, Spencer T, Faraone S, Kessler R, Howes M, Biederman J . Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry. 2006; 18(3):145-8. DOI: 10.1080/10401230600801077. View

20.

Levin F, Evans S, KLEBER H . Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998; 52(1):15-25. DOI: 10.1016/s0376-8716(98)00049-0. View